Candel Therapeutics Inc (NAS:CADL) Stock News, Headlines & Updates
Candel Therapeutics Inc Stock News from GuruFocus
- 1
Jul 09, 2025
Candel Therapeutics (CADL) Gains Buy Rating with $25 Price Target | CADL Stock News
GuruFocus News • 4:15pm
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution
Marketwired • 8:00am
Candel Therapeutics (CADL) Joins Multiple Russell Indexes | CADL Stock News
GuruFocus News • 7:47am
Candel Therapeutics Expands Russell Index Presence with Addition to Multiple Value-Oriented Indexes in 2025 Reconstitution | CADL Stock News
GuruFocus News • 7:15am
Jun 30, 2025
Candel Therapeutics (CADL) Receives Buy Rating from HC Wainwright & Co. | CADL Stock News
GuruFocus News • 6:31am
Jun 24, 2025
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
Marketwired • 9:00am
Candel Therapeutics (CADL) Announces $15 Million Stock Offering to Advance Projects | CADL Stock News
GuruFocus News • 8:31am
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock | CADL Stock News
GuruFocus News • 8:16am
Jun 23, 2025
Candel Therapeutics (CADL) Names Charles Schoch as Permanent CFO | CADL Stock News
GuruFocus News • 1:23pm
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
Marketwired • 8:00am
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer | CADL Stock News
GuruFocus News • 7:16am
Jun 06, 2025
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Marketwired • 8:00am
Candel Therapeutics (CADL) Welcomes New Board Member | CADL Stock News
GuruFocus News • 7:31am
Candel Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors | CADL Stock News
GuruFocus News • 7:15am
Jun 03, 2025
CADL to Present Phase 3 Prostate Cancer Trial Insights | CADL Stock News
GuruFocus News • 10:01am
May 28, 2025
Candel Therapeutics (CADL) Gains on FDA RMAT Designation for CAN-2409
GuruFocus News • 9:58am
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer
Marketwired • 8:00am
Candel Therapeutics (CADL) Receives RMAT Designation for CAN-2409 in Prostate Cancer | CADL Stock News
GuruFocus News • 7:34am
Candel Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for CAN-2409 for the Treatment of Prostate Cancer | CADL Stock News
GuruFocus News • 7:17am
May 27, 2025
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation
Marketwired • 8:00am
Candel Therapeutics (CADL) to Reveal Positive Phase 3 Results for Prostate Cancer | CADL Stock News
GuruFocus News • 7:45am
Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation | CADL Stock News
GuruFocus News • 7:16am
May 22, 2025
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025
Marketwired • 5:00pm
Candel Therapeutics Presents Positive Phase 3 CAN-2409 Results in Localized Prostate Cancer at ASCO 2025 | CADL Stock News
GuruFocus News • 4:16pm
May 13, 2025
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
Marketwired • 8:00am
Candel Therapeutics (CADL) Reports Q1 Earnings and Cash Reserves
GuruFocus News • 7:58am
Candel Therapeutics (CADL) Advances Immunotherapy Pipeline Targeting Prostate Cancer | CADL Stock News
GuruFocus News • 7:53am
CADL's Cash Reserves Projected to Last Until Early 2027 | CADL Stock News
GuruFocus News • 7:32am
Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights | CADL Stock News
GuruFocus News • 7:15am
May 06, 2025
Candel Therapeutics to Present at Upcoming Investor Conferences
Marketwired • 8:00am
Candel Therapeutics to Present at Upcoming Investor Conferences | CADL Stock News
GuruFocus News • 7:15am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news